Carbocisteine can scavenge reactive oxygen species in vitro

Respirology

Volumn 14, Issue 1, 2009, Pages 53-59

  Nogawa, Hisashi ^a   Ishibashi, Yuji ^a   Ogawa, Akitsu ^a   Masuda, Kayoko ^a   Tsubuki, Takeshi ^a   Kameda, Tomoko ^a   Matsuzawa, Shigeki ^a  

^a KYORIN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Biochemistry; Chronic bronchitis; COPD; Emphysema

Indexed keywords

ACETYLCYSTEINE; CARBOCISTEINE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; HYPOCHLOROUS ACID; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ANIMAL CELL; ARTICLE; CELL FREE SYSTEM; IN VITRO STUDY; LIPID OXIDATION; NEUTROPHIL COUNT; NONHUMAN; OXIDATIVE STRESS; PH MEASUREMENT; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT DISEASE;

ANIMALS; BRONCHITIS, CHRONIC; CARBOCYSTEINE; CELLS, CULTURED; EXPECTORANTS; FREE RADICAL SCAVENGERS; HUMANS; LUNG DISEASES; OXIDATION-REDUCTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES;

EID: 58149123625     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2008.01424.x     Document Type: Article

References (24)

1. Macnee W. Oxidative stress and lung inflammation in airways disease. Eur. J. Pharmacol. 2001 429 : 195 207.
2. Barnes PJ. Reactive oxygen species and airway inflammation. Free Radic. Biol. Med. 1990 9 : 235 43.
3. Brigelius-Flohe R, Banning A, Kny M, Bol GF. Redox events in interleukin-1 signaling. Arch. Biochem. Biophys. 2004 423 : 66 73.
4. Simeonova PP, Leonard S, Flood L, Shi X, Luster MI. Redox-dependent regulation of interleukin-8 by tumor necrosis factor-alpha in lung epithelial cells. Lab. Invest. 1999 79 : 1027 37.
5. Roebuck KA. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB [Review Int. J. Mol. Med. 1999 4 : 223 30.
6. Yoshida Y, Maruyama M, Fujita T, Arai N, Hayashi R et al. Reactive oxygen intermediates stimulate interleukin-6 production in human bronchial epithelial cells. Am. J. Physiol. 1999 276 : L900 8.
7. Gillissen A, Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir. Med. 1998 92 : 609 23.
8. Ishibashi Y, Imai S, Inouye Y, Okano T, Taniguchi A. Effects of carbocisteine on sialyl-Lewis x expression in an airway carcinoma cell line stimulated with tumor necrosis factor-alpha. Eur. J. Pharmacol. 2006 530 : 223 8.
9. Puchelle E, Aug F, Polu JM. Effect of the mucoregulator S-carboxy-methyl-cysteine in patients with chronic bronchitis. Eur. J. Clin. Pharmacol. 1978 14 : 177 84.
10. Edwards GF, Steel AE, Scott JK, Jordan JW. S-carboxymethylcysteine in the fluidification of sputum and treatment of chronic airway obstruction. Chest 1976 70 : 506 13.
11. Ohashi Y, Nakai Y, Sugiura Y, Ohno Y, Okamoto H et al. Effect of S-carboxymethylcysteine on ciliary activity in chronic sinusitis. Rhinology 1993 31 : 107 11.
12. Moore RA, Commins D, Bates G, Phillips CJ. S-carboxymethylcysteine in the treatment of glue ear: quantitative systematic review. BMC Fam. Pract. 2001 2 : 3.
13. Tatsumi K, Fukuchi Y. Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease. J. Am. Geriatr. Soc. 2007 55 : 1884 6.
14. Brandolini L, Allegretti M, Berdini V, Cervellera MN, Mascagni P et al. Carbocysteine lysine salt monohydrate (SCMC-LYS) is a selective scavenger of reactive oxygen intermediates (ROIs). Eur. Cytokine Netw. 2003 14 : 20 6.
15. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 1991 10 : 2247 58.
16. Schreck R, Albermann K, Baeuerle PA. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic. Res. Commun. 1992 17 : 221 37.
17. Fuke S, Betsuyaku T, Nasuhara Y, Morikawa T, Katoh H et al. Chemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 2004 31 : 405 12.
18. Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv. Immunol. 1993 54 : 1 78.
19. 4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. Am. J. Respir. Crit. Care Med. 2003 167 : 1109 12.
20. Yasuda H, Yamaya M, Sasaki T, Inoue D, Nakayama K et al. Carbocisteine inhibits rhinovirus infection in human tracheal epithelial cells. Eur. Respir. J. 2006 28 : 51 8.
21. Biagioli MC, Kaul P, Singh I, Turner RB. The role of oxidative stress in rhinovirus induced elaboration of IL-8 by respiratory epithelial cells. Free Radic. Biol. Med. 1999 26 : 454 62.
22. Ishii Y, Kimura T, Morishima Y, Mochizuki M, Nomura A et al. S-carboxymethylcysteine inhibits neutrophil activation mediated by N-formyl-methionyl-leucyl-phenylalanine. Eur. J. Pharmacol. 2002 449 : 183 9.
23. Brown DT. Carbocysteine. Drug Intell. Clin. Pharm. 1988 22 : 603 8.
24. Carpagnano GE, Resta O, Foschino-Barbaro MP, Spanevello A, Stefano A et al. Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys). Eur. J. Pharmacol. 2004 505 : 169 75.